4,258 Shares in Tempus AI, Inc. $TEM Purchased by Mutual Advisors LLC

Mutual Advisors LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 4,258 shares of the company’s stock, valued at approximately $275,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Pathway Capital Management LP bought a new stake in Tempus AI during the first quarter worth about $8,576,000. Sumitomo Mitsui Trust Group Inc. raised its stake in Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after buying an additional 1,016,384 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Tempus AI by 92.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock valued at $27,926,000 after buying an additional 278,311 shares during the period. Cambridge Investment Research Advisors Inc. bought a new stake in Tempus AI in the first quarter valued at approximately $1,019,000. Finally, ARK Investment Management LLC raised its stake in Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after buying an additional 1,981,755 shares during the period. Institutional investors own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Cowen lowered Tempus AI from a “buy” rating to a “hold” rating in a research note on Tuesday. HC Wainwright upped their price objective on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research note on Friday, September 12th. Canaccord Genuity Group assumed coverage on Tempus AI in a research note on Monday. They issued a “buy” rating and a $110.00 price objective on the stock. Guggenheim upped their price objective on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 26th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $75.85.

Insider Buying and Selling at Tempus AI

In related news, COO Ryan Fukushima sold 5,000 shares of the stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $92.32, for a total transaction of $461,600.00. Following the sale, the chief operating officer owned 130,000 shares of the company’s stock, valued at $12,001,600. This represents a 3.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the stock in a transaction that occurred on Thursday, September 25th. The stock was sold at an average price of $76.56, for a total value of $25,456,200.00. Following the sale, the chief executive officer directly owned 9,141,032 shares in the company, valued at $699,837,409.92. This represents a 3.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 933,662 shares of company stock valued at $68,070,993 over the last ninety days. 26.27% of the stock is owned by corporate insiders.

Tempus AI Price Performance

Tempus AI stock opened at $89.10 on Wednesday. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $104.32. The stock’s 50 day moving average is $83.27 and its 200-day moving average is $66.88. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The company has a market capitalization of $15.48 billion, a price-to-earnings ratio of -74.87 and a beta of 4.87.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same quarter in the prior year, the business earned ($6.86) earnings per share. The firm’s revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. Equities research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.